Brief: Opyl Signs 2-Year MoU With Centre For Commercialisation
02/07/2021 03:03
July 2 (Reuters) - Opyl Ltd OPL.AX :
* SIGNS 2-YEAR MOU WITH CENTRE FOR COMMERCIALISATION FOR
REGENERATIVE MEDICINE (CCRM) AUSTRALIA
Source text for Eikon: ID:nASXb3Hc55
Further company coverage: OPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pathkey.AI
See all newsBrief: Pathkey.Ai Posts FY Loss After Tax Of A$3.7 Million
Brief: Pathkey.Ai Announces A$2.8 Million Placement
Brief: Pathkey.AI Seeks Trading Halt Pending Capital Raising Announcement
Brief: Pathkey.AI Appoints Andrew Farnsworth As CEO
Australia's Pathkey.AI soars on deal to buy semiconductor developer